1. Mechanisms of Therapeutic Resistance in Cancer (Stem) Cells with Emphasis on Thyroid Cancer Cells
   Sabine Hombach-Klonisch et al, 2014, Front. Endocrinol. CrossRef
2. Human miR-221/222 in Physiological and Atherosclerotic Vascular Remodeling
   Dmitry A. Chistiakov et al, 2015, BioMed Research International CrossRef
3. Modulation of MicroRNAs by Phytochemicals in Cancer: Underlying Mechanisms and Translational Significance
   Sanjeev K. Srivastava et al, 2015, BioMed Research International CrossRef
4. HMGB1-Induced Cross Talk between PTEN and miRs 221/222 in Thyroid Cancer
   S. Mardente et al, 2015, BioMed Research International CrossRef
5. M2b macrophage polarization accompanied with reduction of long noncoding RNA GAS5
   Ichiaki Ito et al, 2017, Biochemical and Biophysical Research Communications CrossRef
6. Pathological processes and therapeutic advances in radioiodide refractory thyroid cancer
   Marika H Tesselaar et al, 2017, J Mol Endocrinol CrossRef
7. MicroRNA-based molecular classification of papillary thyroid carcinoma
   Francesca Rosignolo et al, 2017 CrossRef
8. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
   Jing Zhang et al, 2014, Int J Oncol CrossRef
9. Action of HMGB1 on miR-221/222 cluster in neuroblastoma cell lines
   Emanuela Mari et al, 2016 CrossRef
10. Bioinformatics analysis of key genes and latent pathway interactions based on the anaplastic thyroid carcinoma gene expression profile
    Yun Huang et al, 2017 CrossRef
11. The interplay between pathogen-associated and danger-associated molecular patterns: an inflammatory code in cancer?
    Monica Escamilla-Tilch et al, 2013, Immunol Cell Biol CrossRef
12. The multifunctional alarmin HMGB1 with roles in the pathophysiology of sepsis and cancer.
    Kerrilyn R Diener et al, 2013, Immunol Cell Biol CrossRef
13. Survival of Mice with Gastrointestinal Acute Radiation Syndrome through Control of Bacterial Translocation
    Fujio Suzuki et al, 2018, J.I. CrossRef
14. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases
    Maryam Zarkesh et al, 2019, Life Sciences CrossRef
15. Deregulation of microRNA expression in thyroid neoplasias
    Pierlorenzo Pallante et al, 2014, Nat Rev Endocrinol CrossRef
16. Follicular cell-derived thyroid cancer
    Henning Dralle et al, 2015, Nat Rev Dis Primers CrossRef
17. MicroRNA signature predicts survival in papillary thyroid carcinoma
    Xiong Chengfeng et al, 2019, J Cell Biochem CrossRef
18. Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer
    Cinzia Antognelli et al, 2019, Cells CrossRef
19. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer
    Pengfei Jiao et al, 2019, Biomedicine & Pharmacotherapy CrossRef
20. Trial Watch
    Erika Vacchelli et al, 2013, OncoImmunology CrossRef
21. Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads.
    Fabrizio Marcucci et al, 2014, Int J Cancer CrossRef
22. MicroRNA in diabetic nephropathy: renin angiotensin, aGE/RAGE, and oxidative stress pathway.
    Shinji Hagiwara et al, 2013, J Diabetes Res CrossRef
23. Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas
    Bartosz Wojtas et al, 2014, Molecular and Cellular Endocrinology CrossRef
24. HMGB1 in Hormone-Related Cancer: a Potential Therapeutic Target
    Madhuwanti Srinivasan et al, 2014, HORM CANC CrossRef
25. The role of miRNAs in cancer: from pathogenesis to therapeutic implications.
    Mehmet Seven et al, 2014, Future Oncol CrossRef
26. HMGB1 in health and disease.
    Rui Kang et al, 2014, Mol Aspects Med CrossRef
27. Hashimoto's thyroiditis and papillary thyroid cancer: are they immunologically linked?
    Margret Ehlers et al, 2014, Trends in Endocrinology & Metabolism CrossRef
28. Integrated genomic characterization of papillary thyroid carcinoma.
    , 2014, Cell CrossRef
29. GNAI3 inhibits tumor cell migration and invasion and is post-transcriptionally regulated by miR-222 in hepatocellular carcinoma
    Yu Zhang et al, 2015, Cancer Letters CrossRef
30. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis
    Ruiguang Zhang et al, 2015, Tumor Biol. CrossRef
31. MECHANISMS IN ENDOCRINOLOGY: MicroRNA in diagnostics and therapy of thyroid cancer
    Anna Wójcicka et al, 2016 CrossRef
32. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3
    Rui Li et al, 2016, Tumor Biol. CrossRef
33. Scavenger receptors and non-coding RNAs: relevance in atherogenesis
    Yao Dai et al, 2016, Cardiovasc Res CrossRef
34. MicroRNAs and Lymph Node Metastasis in Papillary Thyroid Cancers
    Nurul-Syakima Ab Mutalib et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
35. MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma
    Yingbin Diao et al, 2017, American Journal of Therapeutics CrossRef
36. Alarmins and Antitumor Immunity
    Yingjie Nie et al, 2016, Clinical Therapeutics CrossRef
37. null
    I. Ugrinova et al, 2017 CrossRef
38. Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression
    Huijuan Jiang et al, 2017, Radiat Oncol CrossRef
39. Role of miR-221/222 in Tumor Development and the Underlying Mechanism
    Qian Song et al, 2019, Journal of Oncology CrossRef
40. Circular RNA circFOXM1 Plays a Role in Papillary Thyroid Carcinoma by Sponging miR-1179 and Regulating HMGB1 Expression
    Mao Ye et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
41. Propofol upregulates miR-320a and reduces HMGB1 by downregulating ANRIL to inhibit PTC cell malignant behaviors
    Mengyuan Li et al, 2020, Pathology - Research and Practice CrossRef
42. Glycyrrhizin Protects γ-Irradiated Mice from Gut Bacteria–Associated Infectious Complications by Improving miR-222–Associated Gas5 RNA Reduction in Macrophages of the Bacterial Translocation Site
    Ichiaki Ito et al, 2020, J.I. CrossRef
43. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival
    Xiaodan Fu et al, 2016, Oncotarget CrossRef
44. Involvement of HMGB1 in vemurafenib resistance in thyroid cancer cells harboring BRAF (V600E) mutation by regulating excessive autophagy.
    Lin Run et al, 2021, Endocrine CrossRef
45. AGE-RAGE synergy influences programmed cell death signaling to promote cancer
    Bhargav N. Waghela et al, 2020, Mol Cell Biochem CrossRef
46. High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.
    Man Chen et al, 2015, Cancer Res. CrossRef
47. MiR-153-3p Suppresses Cell Proliferation, Invasion and Glycolysis of Thyroid Cancer Through Inhibiting E3F3 Expression
    Xianzhao Deng et al, 2021, OTT CrossRef
48. Activated M1 macrophages suppress c-kit expression via TNF-α-mediated upregulation of miR-222 in Neonatal Necrotizing Enterocolitis
    Xue Xia et al, 2021, Inflamm. Res. CrossRef
49. Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression
    Agnieszka Bronowicka-Szydełko et al, 2021, JCM CrossRef
50. MicroRNA-Based Risk Score for Predicting Tumor Progression Following Radioactive Iodine Ablation in Well-Differentiated Thyroid Cancer Patients: A Propensity-Score Matched Analysis
    Eman A. Toraih et al, 2021, Cancers CrossRef
51. The Importance of miRNA in the Diagnosis and Prognosis of Papillary Thyroid Cancer
    Mariusz Rogucki et al, 2021, JCM CrossRef
52. Papillary Thyroid Cancer Prognosis: An Evolving Field.
    Salvatore Ulisse et al, 2021, Cancers (Basel) CrossRef
53. MiR-221 Regulates Suppressors of Cytokine Signaling 3-Janus Kinase 2/Signal Transducer and Activator of Transcription 3 (SOCS3-JAK2/STAT3) Pathway and Affects Thyroid Cancer Cell Proliferation and Apoptosis
    Neng Jiang et al, 2022, j biomater tissue eng CrossRef
54. MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment
    Maria Papaioannou et al, 2022, Front. Oncol. CrossRef
55. High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases
    Simona Taverna et al, 2022, Cells CrossRef
56. Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma
    Ying Xin et al, 2022, CCHTS CrossRef
57. Extra-Cellular Vesicles Derived from Thyroid Cancer Cells Promote the Epithelial to Mesenchymal Transition (EMT) and the Transfer of Malignant Phenotypes through Immune Mediated Mechanisms
    Stefania Mardente et al, 2023, IJMS CrossRef
58. Fibrosis as a Risk Factor for Cutaneous Squamous Cell Carcinoma in Recessive Dystrophic Epidermolysis Bullosa: A Systematic Review
    Brenda Lamônica Rodrigues de Azevedo et al, 2023, J Pediatr Genet CrossRef
59. CircRTN1 stimulates HMGB1 to regulate the malignant progression of papillary thyroid cancer by sponging miR-101-3p
    Mei Zheng et al, 2023, Hormones CrossRef